An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Post time 1 hour(s) ago

journal：Blood

Authors：Meletios A. Dimopoulos; Antonio Palumbo; Paolo Corradini; Michele Cavo; Michel Delforge; Katja C. Weisel; Enrique M. Ocio; Francesco Di Raimondo; Markus Hansson; Mathew Simcock; Neil Miller; Ana Slaughter; Teresa Peluso; Lars Sternas; Mohamed H Zaki; Philippe Moreau

Published date：2015-12-3

DOI：10.1182/blood.v126.23.4225.4225

PDF link：https://ashpublications.org/bloo ... Stratus-Trial-MM010

Article link：https://doi.org/10.1182/blood.v126.23.4225.4225

Article Source：American Society of Hematology。

Remark：

[Other] An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)